Suppr超能文献

[突眼性甲状腺肿的治疗。选择的痛苦]

[The treatment of Basedow's disease. The agony of selection].

作者信息

Bürgi H, Maurer W, Probst P

出版信息

Schweiz Med Wochenschr. 1986 Feb 8;116(6):162-9.

PMID:2419976
Abstract

The treatment mode of Graves' disease should be chosen individually for each patient. This requires a thorough knowledge of the advantages and disadvantages of the various methods, and also bias-free interdisciplinary cooperation. Surgery reestablishes euthyroidism in about 80%, with 10% becoming hypothyroid. In centers practising more radical surgery hypothyroidism has developed in up to 49% and there is now evidence of occurrence of late hypothyroidism in the same way as after radioiodine. Radioiodine is cheap and causes minimal inconvenience to the patient. Because prevalence of hypothyroidism rises in a cumulative way over decades, lifelong follow-up is necessary with an examination every 1 to 2 years. The genetic risk and the danger of thyroid carcinoma have been shown to be negligible by gonadal dose calculations and by longterm prospective follow-up. Antithyroid drugs inhibit incorporation of iodide into thyroglobulin and produce rapid clinical improvement. It seems probable that, in longterm treatment, they also specifically suppress the synthesis of thyroid-stimulating immunoglobulins. The significance of "allergic" reactions such as skin rash, leukopenia and agranulocytosis is usually overestimated. The hematologic side effects are rare, dose-related and reversible in most cases. The major drawback of antithyroid drugs is the high recurrence rate (50%) of hyperthyroidism after cessation of therapy. It is still undecided whether a long course of treatment (one year or longer) produces better longterm results than short courses.

摘要

格雷夫斯病的治疗方式应针对每位患者进行个体化选择。这需要全面了解各种方法的优缺点,以及无偏见的多学科合作。手术可使约80%的患者恢复甲状腺功能正常,其中10%会出现甲状腺功能减退。在实施更激进手术的中心,甲状腺功能减退的发生率高达49%,现在有证据表明,与放射性碘治疗后一样,会出现晚期甲状腺功能减退。放射性碘价格便宜,给患者带来的不便最小。由于甲状腺功能减退的患病率在几十年中呈累积上升趋势,因此需要终身随访,每1至2年进行一次检查。通过性腺剂量计算和长期前瞻性随访表明,遗传风险和甲状腺癌的风险可忽略不计。抗甲状腺药物可抑制碘化物掺入甲状腺球蛋白,并能迅速改善临床症状。长期治疗时,它们似乎还能特异性抑制促甲状腺素受体抗体的合成。诸如皮疹、白细胞减少和粒细胞缺乏症等“过敏”反应的重要性通常被高估了。血液学副作用很少见,与剂量相关,且在大多数情况下是可逆的。抗甲状腺药物的主要缺点是停药后甲亢的复发率较高(50%)。长期治疗(一年或更长时间)是否比短期治疗产生更好的长期效果仍未确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验